Expression and regulation of CC class chemokines in the dystrophic (mdx) diaphragm

被引:32
作者
Demoule, A
Divangahi, M
Danialou, G
Gvozdic, D
Larkin, G
Bao, WS
Petrof, BJ
机构
[1] McGill Univ, Meakins Christie Labs, Montreal, PQ, Canada
[2] McGill Univ, Ctr Hlth, Montreal, PQ, Canada
关键词
chemokine receptors; Duchenne muscular dystrophy; inflammation; macrophage inflammatory protein-1 alpha; RANTES; skeletal muscle;
D O I
10.1165/rcmb.2004-0347OC
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the murine (mdx) model of Duchenne muscular dystrophy, dystrophic changes are much more severe in the diaphragm than in limb muscles, and the diaphragm more closely resembles the human disease phenotype. Chemokines could play a central role in governing such phenotypic differences, as inflammation is an important disease modifier. Here we report that CC chemokine receptors (CCRs 1, 2, 3, 5) and ligands (macrophage inflammatory protein-let, RANTES) are expressed at higher levels in dystrophic than in wild-type muscles across age groups (6, 12, and 24 wk). Moreover, chemokine ligand expression and muscle inflammation are significantly higher in dystrophic diaphragms than in limb muscles of the same animals. In vitro, CCR1 is constitutively expressed by cultured primary diaphragmatic myotubes. Stimulation of myotubes by proinflammatory cytokines (tumor necrosis factor-a, interleukin-la, interferon-gamma) found within the in vivo dystrophic muscle environment, upregulates CCR1 in mdx and wild-type cultures, and also increases expression of its ligand RANTES to a significantly greater degree in the mdx group. Taken together, our results suggest that CC chemokines may play an important role in sustaining inflammation within the mdx diaphragm, which could help acount for its more severe phenotype and also offer a target for therapeutic intervention in Duchenne patients.
引用
收藏
页码:178 / 185
页数:8
相关论文
共 39 条
  • [1] Adams EM, 1997, P ASSOC AM PHYSICIAN, V109, P275
  • [2] Bartoli C, 2001, ACTA NEUROPATHOL, V102, P385
  • [3] Eosinophilia of dystrophin-deficient muscle is promoted by perforin-mediated cytotoxicity by T cell effectors
    Cai, BY
    Spencer, MJ
    Nakamura, G
    Tseng-Ong, L
    Tidball, JG
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (05) : 1789 - 1796
  • [4] MOLECULAR-CLONING AND FUNCTIONAL EXPRESSION OF 2 MONOCYTE CHEMOATTRACTANT PROTEIN-1 RECEPTORS REVEALS ALTERNATIVE SPLICING OF THE CARBOXYL-TERMINAL TAILS
    CHARO, IF
    MYERS, SJ
    HERMAN, A
    FRANCI, C
    CONNOLLY, AJ
    COUGHLIN, SR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (07) : 2752 - 2756
  • [5] Expression profiling in the muscular dystrophies: Identification of novel aspects of molecular pathophysiology
    Chen, YW
    Zhao, P
    Borup, R
    Hoffman, EP
    [J]. JOURNAL OF CELL BIOLOGY, 2000, 151 (06) : 1321 - 1336
  • [6] Pharmacological characterization of the chemokine receptor, hCCR1 in a stable transfectant and differentiated HL-60 cells:: antagonism of hCCR1 activation by MIP-1β
    Chou, CC
    Fine, JS
    Pugliese-Sivo, C
    Gonsiorek, W
    Davies, L
    Deno, G
    Petro, M
    Schwarz, M
    Zavodny, PJ
    Hipkin, RW
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2002, 137 (05) : 663 - 675
  • [7] Chemotactic factors enhance myogenic cell migration across an endothelial monolayer
    Corti, S
    Salani, S
    Del Bo, R
    Sironi, M
    Strazzer, S
    D'Angelo, MG
    Comi, GP
    Bresolin, N
    Scarlato, G
    [J]. EXPERIMENTAL CELL RESEARCH, 2001, 268 (01) : 36 - 44
  • [8] DEMOULE A, 2004, AM J RESP CRIT CARE, V169, pA244
  • [9] Fang J, 2000, J CELL BIOCHEM, V79, P164, DOI 10.1002/1097-4644(2000)79:1<164::AID-JCB10>3.0.CO
  • [10] 2-D